ICP DAS-BMP Showcases Innovative TPU Solutions at COMPAMED 2025

Introduction
ICP DAS-BMP, a prominent player in the biomedical polymers sector, is set to make a significant impact at the upcoming COMPAMED 2025, taking place from November 17 to 20, 2025, at Messe Düsseldorf, Germany. This Taiwanese manufacturer is renowned for its high-quality medical-grade thermoplastic polyurethane (TPU), and this year, it will highlight its latest innovations aimed at improving medical device manufacturing.

New Innovations in TPU Technology
Among the new offerings slated for presentation are the Low-Migration Series and the Low-Friction Series. The Low-Migration Arothane™ ARP-B20 TPU is a standout product that complies with ISO 10993 standards, making it suitable for implantation procedures up to 90 days. What sets this TPU apart is its ability to minimize additive migration during the manufacturing process, ensuring that catheters maintain a smooth surface throughout their shelf life—an essential feature for ensuring patient safety and device efficacy. Furthermore, it comes in 15 distinct colors, allowing for greater customization in design.

The Low-Friction Series is another exciting innovation designed with an inherently smooth surface. This TPU eliminates the need for additional coatings or post-processing treatments, thereby simplifying the manufacturing process. Free from harmful chemical compounds like PFAS and plasticizers, this series guarantees long-term stability without the risk of surface exudation or additive migration. The low-friction characteristics make it particularly suitable for applications requiring easy insertion, such as nasogastric tubes with guidewires, ultimately enhancing safety and performance during both storage and use.

Comprehensive TPU Portfolio
In addition to these innovative offerings, ICP DAS-BMP will present a diverse range of TPU solutions catering to various medical requirements. The ARP, ALP, and ALC series meet the demands of most body-contact devices, with specific grades like ARP-B20 and ALC-B40 qualified for 90-day implantation. The company also produces radiopaque TPUs like the ARP-W and ARP-WG series, which incorporate 40–60% tungsten to improve visibility in guidewires and thin-walled devices. Moreover, the Engineering Arothane™ EARP series is recognized for its clarity and strength, making it ideal for precision devices such as orthodontics and Luer-Lock connectors.

Commitment to Quality and Innovation
ICP DAS-BMP’s dedication to advancing the field of medical materials is evident in its focus on creating safer, more reliable, and versatile TPU solutions. Their ongoing innovation allows medical device manufacturers to adapt to the ever-evolving landscape of modern healthcare effectively. The company, certified under ISO 13485, utilizes over thirty years of expertise in industrial automation to ensure top-notch quality management. The state-of-the-art laboratories they operate enable them to enhance product quality while optimizing delivery timelines.

Conclusion
Attendees at COMPAMED 2025 are encouraged to visit ICP DAS-BMP at Hall 8b, Booth C09-4 to explore firsthand these pioneering TPU innovations that promise to revolutionize medical device manufacturing. With a commitment to responsive customer service and flexible solutions—including accommodating smaller order quantities—ICP DAS-BMP is poised to meet the diverse needs of its customers while fostering long-lasting partnerships in the medical device sector.

For more information about ICP DAS-BMP and its products, visit ICP DAS-BMP Website.